Jump to Navigation

Combined Antidepressants No More Effective than Monotherapy

The well known Star*D trial yielded disappointingly low remission and response rates in depressed patients who were put on citalopram (Celexa) for eight weeks. Recently, some clinicians have advocated starting depressed patients with a combination of antidepressants, in the hopes that targeting multiple neurotransmitters will boost efficacy.

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.